产品名称	SW 982 [SW-982, SW982]人滑膜肉瘤细胞
货号	ZQ0406
产品介绍	SW 982 [SW-982，SW982] 是一种表现出混合形态的细胞系，分离自一名 25 岁白人女性滑膜肉瘤患者的滑膜（关节）。该细胞系由 A. Leibovitz 于 1974 年在德克萨斯州坦普尔的 Scott and White 诊所从双相滑膜肉瘤的手术标本中建立。组织病理学评估表明为与脂肪肉瘤一致的未分化恶性肿瘤。 1982年１月ATCC收到１支传代至4代的冻存管。
种属	人
性别/年龄	女/25岁
组织	滑膜
疾病	滑膜肉瘤
细胞类型	肿瘤细胞
形态学	混合型
生长方式	贴壁
倍增时间	大约48~72小时
培养基和添加剂（默认）	DMEM/F12（中乔新舟 货号：ZQ-600）+10%FBS（中乔新舟 货号：ZQ0500）+1%双抗（中乔新舟   货号：CSP006） 注意默认方案培养条件：95%空气，5%CO2；37℃
培养方案B（可选）	L-15基础（中乔新舟 货号：ZQ-1100）+10%胎牛血清（中乔新舟  货号：ZQ500-A）+1%P/S（中乔新舟 货号：CSP006） 注意B方案培养条件：100%空气；37℃
推荐默认完全培养基货号	ZM0406
B方案完全培养基货号	ZM0406-B
生物安全等级	BSL-1
STR位点信息	Amelogenin: X CSF1PO: 11,12 D13S317: 12,13 D16S539: 11,12 D5S818: 11,13 D7S820: 9,11 THO1: 9.3 TPOX: 9,11 vWA: 19,20
默认方案培养条件	95%空气，5%CO2；37℃
抗原表达/受体表达	***
基因表达	***
保藏机构	ATCC; HTB-93
供应限制	仅供科研使用

货号	ZQ0406
发货规格	活细胞：T25培养瓶*1瓶或者1ml 冻存管*1支（细胞量约为5 x 10^5 cells/vial）二选一
发货形式	活细胞：常温运输；冻存管：干冰运输
储存温度	活细胞：培养箱；冻存管：液氮罐
产地	中国
供应限制	仅供科研使用

论文标题： Sprouty2 Inhibits Migration and Invasion of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Down-regulating ATF2 Expression and Phosphorylation
DOI： 10.1007/s10753-020-01311-z
发表时间： 2020-08-12
期刊： INFLAMMATION
影响因子： 3.212
货号： ZQ0406
产品名称： SW982 cells

原文链接： https://link.springer.com/article/10.1007/s10753-020-01311-z

PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

DOI=10.1007/978-94-011-3550-4_4
Hay R.J.
Development, availability and characterization of ATCC human and animal cell lines.
(In) Animal cell culture and production of biologicals; Sasaki R., Ikura K. (eds.); pp.27-39; Springer; Dordrecht (1991)

PubMed=15038780; DOI=10.1290/1543-706X(2003)039<0337:PCOAHS>2.0.CO;2
Yamazaki T., Yokoyama T., Akatsu H., Tukiyama T., Tokiwa T.
Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone.
In Vitro Cell. Dev. Biol. Anim. 39:337-339(2003)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074
Teicher B.A., Polley E.C., Kunkel M., Evans D., Silvers T.E., Delosh R.M., Laudeman J., Ogle C., Reinhart R., Selby M., Connelly J., Harris E., Monks A., Morris J.
Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.
Mol. Cancer Ther. 14:2452-2462(2015)